Long-term oncologic outcomes following neoadjuvant therapy and transanal excision of T2 or T3 rectal cancer. Khan S, Guardado J, Mahler B, Salgado J, et al. Am J Surg 2021;221:620-621.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khan S, Guardado J, Mahler B, Salgado J, et al. Long-term oncologic outcomes following neoadjuvant therapy and transanal excision of T2 or T3 rectal cancer. Am J Surg 2021;221:620-621.
PMID: 32951854